XML 66 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
 9 Months Ended
Feb. 24, 2013
Feb. 26, 2012
Consolidated net income $ 18,227,000 $ 10,205,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,527,000 4,111,000
Stock-based compensation expense 1,135,000 1,314,000
Tax benefit from stock-based compensation expense (2,743,000) (5,511,000)
Loss on disposal of property and equipment 180,000  
Deferred taxes 4,230,000 157,000
Change in contingent consideration (3,933,000)  
Change in investment in non-public company (fair market value) (6,300,000) (4,726,000)
Accounts receivable, net (5,316,000) (1,718,000)
Accounts receivable, related party 11,000 75,000
Income taxes receivable 2,790,000 5,870,000
Inventories (374,000) 229,000
Issuance of notes and advances receivable (4,171,000) (3,699,000)
Collection of notes and advances receivable 3,586,000 3,196,000
Prepaid expenses and other current assets (3,035,000) 3,577,000
Accounts payable 5,096,000 (2,295,000)
Related party accounts payable (585,000) (83,000)
Accrued compensation 131,000 837,000
Other accrued liabilities (2,564,000) (691,000)
Deferred revenue 1,583,000 (2,313,000)
Net cash provided by operating activities 13,475,000 8,535,000
Purchases of property and equipment (4,538,000) (3,892,000)
Purchase of marketable securities (5,239,000) (25,679,000)
Proceeds from maturities and sale of marketable securities   9,100,000
Net cash used in investing activities (8,328,000) (862,000)
Repurchase of outstanding common stock   (5,007,000)
Proceeds from sale of common stock 1,385,000 91,000
Taxes paid by Company for stock swaps and RSUs (49,000) (38,000)
Tax benefit from stock-based compensation expense 2,743,000 5,511,000
Earn out payment from Lifecore acquisition (9,650,000)  
Principal payments on long-term debt (4,476,000) (3,330,000)
Payments on lines of credit (7,666,000)  
Decrease (Increase) in other assets 652,000 (244,000)
Payments to minority interest holders (320,000) (257,000)
Net cash used in financing activities (17,381,000) (3,274,000)
Net (decrease) increase in cash and cash equivalents (12,234,000) 4,399,000
Cash and cash equivalents at beginning of period 22,177,000 [1] 8,135,000
Cash and cash equivalents at end of period 9,943,000 12,534,000
Unrealized gain from interest rate swap   65,000
Earnout [Member]
    
Adjustments to reconcile net income to net cash provided by operating activities:    
Change in contingent consideration (3,933,000)  
Change In Value [Member]
    
Adjustments to reconcile net income to net cash provided by operating activities:    
Change in contingent consideration 3,933,000  
Marketable Maturities [Member]
    
Adjustments to reconcile net income to net cash provided by operating activities:    
Proceeds from maturities and sale of marketable securities 1,449,000 19,581,000
Marketable Sales [Member]
    
Adjustments to reconcile net income to net cash provided by operating activities:    
Proceeds from maturities and sale of marketable securities   $ 9,128,000
[1] Derived from audited financial statements.